Author

Xiangfei Yuan

Observed name: Xiang‐Fei Yuan

Institution: Tianjin Nankai Hospital

Observed institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin Nankai Hospital, Institute of Hematology & Blood Diseases Hospital, State Key Laboratory of Experimental Hematology, Tianjin Medical University

ORCID: 0000-0003-1723-9627

Observed ORCID: 0000-0003-1723-9627

OpenAlex ID: A5040838541

Dihydroartemisinin inhibits the growth of pancreatic cells by inducing ferroptosis and activating antitumor immunity

2022 · Hongbo Zhang, Yuzhen Zhuo, et al. · European Journal of Pharmacology · 58

Surface expression of anti‐CD3scfv stimulates locoregional immunotherapy against hepatocellular carcinoma depending on the E1A‐engineered human umbilical cord mesenchymal stem cells

2017 · Qing Zhang, Xiang‐Fei Yuan, et al. · International Journal of Cancer · 11

Isobavachalcone Activates Antitumor Immunity on Orthotopic Pancreatic Cancer Model: A Screening and Validation

2022 · Hongbo Zhang, Xuanming Liu, et al. · Research Square · 1

Isobavachalcone Activates Antitumor Immunity on Orthotopic Pancreatic Cancer Model: A Screening and Validation

2022 · Hongbo Zhang, Xuanming Liu, et al. · Research Square · 1

Ubiquitin-specific peptidase 20 affects immune cell infiltration by regulating prostaglandin E2 on intraperitoneal metastasis model of colorectal cancer

2025 · Yang Hua, Xiukun Ma, et al. · Translational Cancer Research

RETRACTED: Improved conditionally replicative adenovirus delivery system against hepatocellular carcinoma by armed with bispecific T-cell engager

2022 · Xiangfei Yuan, Yang Lu, et al. · Research Square

Works count: 6

Citation count: 71

H-index: 2

I10-index: 2